comparemela.com
Home
Live Updates
Prnewswire Vivacelle Bio Inc - Breaking News
Pages:
Latest Breaking News On - Prnewswire vivacelle bio inc - Page 1 : comparemela.com
Vivacelle Bio s VBI-S Phase IIa Clinical Trial Meets Primary and Secondary Endpoints for Treating Hypovolemia in Septic Shock Patients
/PRNewswire/ Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic.
United states
Kansas city
Harven deshield
Naval medical research center
School of medicine
Prnewswire vivacelle bio inc
Us army medical research
Drug administration
Vivacelle bio inc
Naval advanced medical development
Trauma services
Technology enterprise consortium
Development command
Sosland missouri endowed chair
Chief innovation officer
Vivacelle bio
vimarsana © 2020. All Rights Reserved.